Cargando…

Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”

Detalles Bibliográficos
Autores principales:	Sindelar, Morganne, McCabe, Daniel, Carroll, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	The Poison Pen
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054203/ https://www.ncbi.nlm.nih.gov/pubmed/36988815 http://dx.doi.org/10.1007/s13181-023-00940-8

Ejemplares similares

Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
por: de Oliveira, Luciana Mello, et al.
Publicado: (2023)

Tacrolimus Drug–Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin
por: Sindelar, Morganne, et al.
Publicado: (2022)

Comment on “An Increase in Dietary Supplement Exposures Reported to US Poison Control Centers”
por: Kingston, Richard L., et al.
Publicado: (2017)

The Importance of Continuing Medical Education During the COVID-19 Pandemic: the Global Educational Toxicology Uniting Project (GETUP)
por: Wong, Anselm, et al.
Publicado: (2020)

In Reply to “Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion?”
por: Chai, P. R., et al.
Publicado: (2020)

Drug Interaction Between Tacrolimus and Paxlovid (Nirmatrelvir/Ritonavir) in an Adolescent with Inflammatory Bowel Disease
por: Zaarur, Leenoy, et al.
Publicado: (2023)

Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
por: Kwon, Eun-Jeong, et al.
Publicado: (2022)

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
por: Marzolini, Catia, et al.
Publicado: (2022)

Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
por: Bihan, Kevin, et al.
Publicado: (2023)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Overview of Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy and Supportive Care for Lung Cancer
por: Anwar, Kaleem, et al.
Publicado: (2022)

Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
por: Hashemian, Seyed Mohammad Reza, et al.
Publicado: (2023)

Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant
por: Young, Chelsea, et al.
Publicado: (2022)

Le nirmatrelvir-ritonavir (Paxlovid®), un traitement contre la Covid-19
por: Buxeraud, Jacques, et al.
Publicado: (2022)

Injury Secondary to Antiretroviral Agents: Retrospective Analysis of a Regional Poison Center Database
por: Wheatley, Matthew A., et al.
Publicado: (2011)

Intentional Ethylene Glycol Poisoning Increase after Media Coverage of Antifreeze Murders
por: Morgan, Brent W., et al.
Publicado: (2011)

Suicide Fads: Frequency and Characteristics of Hydrogen Sulfide Suicides in the United States
por: Reedy, Sarah Jane D., et al.
Publicado: (2011)

Differences in Poisoning Mortality in the United States, 2003–2007: Epidemiology of Poisoning Deaths Classified as Unintentional, Suicide or Homicide
por: Muazzam, Sana, et al.
Publicado: (2012)

The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between M(pro) and antiviral drugs (nirmatrelvir and ritonavir)
por: Dawood, Ali Adel
Publicado: (2023)

511. Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment For COVID-19
por: Bhargava, Ashish, et al.
Publicado: (2023)

DRUG INTERACTION BETWEEN PAXLOVID AND TACROLIMUS IN AN ADOLESCENT WITH INFLAMMATORY BOWEL DISEASE
por: Zaarur, Leenoy, et al.
Publicado: (2023)

Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report
por: Prikis, Marios, et al.
Publicado: (2022)

WCN23-0117 PAXLOVID ( NIRMATRELVIR/RITONAVIR ) AND CYCLOSPORIN IN A KIDNEY TRANSPLANT PATIENT WITH COVID-19 INFECTION
por: Then, R.F., et al.
Publicado: (2023)

Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations
por: Cohen, Alison K., et al.
Publicado: (2023)

Paxlovid (Nirmatrelvir and Ritonavir) Use in Pregnant and Lactating Woman: Current Evidence and Practice Guidelines—A Scoping Review
por: Chourasia, Prabal, et al.
Publicado: (2023)

Drug Interactions With Nirmatrelvir-Ritonavir in Older Adults Using Multiple Medications
por: Ross, Sydney B., et al.
Publicado: (2022)

Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
por: Vazquez, Sara R., et al.
Publicado: (2022)

Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters
por: Bakos, Éva, et al.
Publicado: (2023)

Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware
por: Ratain, Mark J., et al.
Publicado: (2022)

Ozymandias
por: Young, James B.
Publicado: (2021)

Do Not Go Gentle Into That Good Night
por: Young, James B.
Publicado: (2022)

The Fisherman
por: Young, James B.
Publicado: (2021)

The Wound Dresser
por: Young, James B.
Publicado: (2022)

Gertrude Stein: A Physician Who Wasn’t to Be
por: Young, James B.
Publicado: (2022)

The Noncompliant Patient
por: Young, James B., et al.
Publicado: (2022)

Up-Hill: An Allegory
por: Young, James B.
Publicado: (2023)

Truman Capote as a Poet
por: Young, James B.
Publicado: (2023)

Old Ironsides
por: Young, James B.
Publicado: (2023)

In Flanders Fields: John McCrae as Physician, Poet, Soldier
por: Young, James C.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vcq10atr0gt1hco09tf6uig644